• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

SPDR Barclays Sterling Corporate Bond UCITS ETF

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider State Street Global Advisors Ltd
Fund Summary The objective of the Fund is to track the performance of the Sterling-denominated corporate bond market for fixed-rate, investment grade (high quality) securities.
SEDOL code B4694Z1
ISIN IE00B4694Z11
Fund code XBCBI
Managers Not Disclosed
Manager Tenure 8 years
Morningstar Category GBP Corporate Bond
Fund Size £256 million
Fund Type ETF / IT
Management Style Passive
Ongoing Charge Figure (OCF) 0.2%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £63.8062
Buy Price £64.0640
Price Date 29th May 2020
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 22nd July 2019
Fund Status OPEN

3-year Mean Monthly Return: 0.327%

Annual Returns 2019 2018 2017 2016 2015 2014 2013
Fund Performance -0.43% +4.18% +1.27% +10.03% +0.40% +13.91% +1.45%
Benchmark Performance
(GBP Corporate Bond)
+0.66% +3.07% +1.49% +9.43% -0.52%
Time Period Cumulative Benchmark Performance
(GBP Corporate Bond)
Fund Compared to Benchmark
1 day 0.00% +1.33% -1.33%
1 week 1.41% +1.33% +0.08%
1 month 1.01% -0.89% +1.90%
3 months 0.23% +1.25% -1.02%
6 months 2.10% +6.04% -3.94%
1 year 7.63% +3.15% +4.48%
3 years 3.72% +4.32% -0.61%
5 years 5.02% +5.54% -0.51%
10 years Currently unavailable Currently unavailable Currently unavailable
YTD 1.92% +0.76% +1.16%
Since inception Currently unavailable Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Engie 5% FRA 0.62%
ENEL Finance International N.V. 5.75% ITA 0.49%
Barclays Bank plc 10% GBR 0.45%
WALMART INC 5.25% USA 0.43%
Pfizer Inc. 2.74% USA 0.42%
AT&T Inc 7% USA 0.41%
GlaxoSmithKline Capital plc 5.25% GBR 0.41%
Bank of America Corporation 7% USA 0.41%
T.H.F.C. (FUNDING NO.3) PLC 5.2% GBR 0.40%
GlaxoSmithKline Capital plc 5.25% GBR 0.38%
Dividend Date Per share amount Reinvestment Price
3rd February 2020 0.8410 £64.2400
1st August 2019 0.8207 £62.6750
1st February 2019 0.7694 £58.8700
1st August 2018 0.8399 £58.8700
1st February 2018 0.7330 £60.2100
1st August 2017 1.0009 £60.9600